This PDF is the current document as it appeared on Public Inspection on 03/13/2014 at 08:45 am.
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, RFA-DK-13-010 Type 1 Diabetes TrialNet Clinical Centers (U01).
Date: April 7-8, 2014.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate cooperative agreement applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 759, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-594-2242, email@example.com.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology Start Printed Page 14524and Hematology Research, National Institutes of Health, HHS)Start Signature
Dated: March 10, 2014.
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-05541 Filed 3-13-14; 8:45 am]
BILLING CODE 4140-01-P